R3 Vascular Announces $87 Million in Series B Financing
R3 Vascular will use the proceeds to support the ELITE FDA IDE pivotal trial of its best-in-class bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD.
- Go to the previous page
- 1
- …
- 720
- 721
- 722
- 723
- 724
- 725
- 726
- …
- 5,619
- Go to the next page